Gianfranco Ferraccioli

Centro Studi GISED — Italy

Medicine · Health Sciences

78h-index34.7kcitations657works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(246), Systemic Lupus Erythematosus Research(188), Systemic Sclerosis and Related Diseases(96), Monoclonal and Polyclonal Antibodies Research(83), Chronic Lymphocytic Leukemia Research(69)

Publications654 total

Has the time come to change the treatment criteria for patients with chronic kidney disease? The “hypofiltering nephron” hypothesis
Frontiers in Nephrology·2025Open Access
ABS0772 BASELINE DETERMINANTS OF MINIMAL DISEASE ACTIVITY (MDA) AT 12 MONTHS IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH GUSELKUMAB: AN ITALIAN MULTICENTER REAL-WORLD STUDY
Annals of the Rheumatic Diseases·2025Open Access
POS0817 SEX-BASED DIFFERENCES IN 24-MONTH TREATMENT OUTCOMES WITH b/ts-DMARDs IN PSORIATIC ARTHRITIS: REAL-WORLD EVIDENCE AND PREDICTIVE MODELING FROM THE GRUPPO ITALIANO STUDIO EARLY ARTHRITIS (GISEA) MULTICENTER PROSPECTIVE REGISTRY
Annals of the Rheumatic Diseases·2025
CAR T-cell perspectives in lupus
The Lancet·2024· 1 cited
POS0671 PROFILE AND MANAGEMENT OF D2T-RA PATIENTS IN THE ITALIAN GISEA REGISTRY
Annals of the Rheumatic Diseases·2024
B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren’s Disease: A Pilot Monocentric Exploratory Study
International Journal of Molecular Sciences·2024· 10 citedOpen Access
Difficult to treat rheumatoid arthritis: Sequential therapy with different personalized biological targets could be an option
European Journal of Internal Medicine·2024
Severe hand deformities in an undertreated condition
European Journal of Internal Medicine·2023Open Access
COVID‐19 illness: Different comorbidities may require different immunological therapeutic targets
European Journal of Clinical Investigation·2023· 4 citedOpen Access
Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice
Journal of Clinical Medicine·2023· 117 citedOpen Access
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry
Clinical and Experimental Rheumatology·2023· 5 cited
Albumin: A Biomarker to Be Repurposed
Preprints.org·2023· 21 citedOpen Access
POS0852 REAL LIFE DATA OF FILGOTINIB IN RHEUMATOID ARTHRITIS PATIENTS: DATA FROM ITALIAN GISEA REGISTRY
Annals of the Rheumatic Diseases·2023· 1 citedOpen Access
POS1075 RETENTION RATE OF BIOLOGIC AND TARGETED SYNTHETIC ANTI-RHEUMATIC DRUGS IN ELDERLY PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS: DATA FROM ITALIAN GISEA REGISTRY
2023Open Access
Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium”
Journal of Clinical Medicine·2023· 10 citedOpen Access
Case report: crowned dens syndrome in a patient with seronegative rheumatoid arthritis
RMD Open·2023· 3 citedOpen Access
The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 – Unmet needs and therapeutic perspectives
Frontiers in Medicine·2023· 35 citedOpen Access
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs
Clinical and Experimental Rheumatology·2023· 5 citedOpen Access
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM
Lara D. Veeken·2023· 10 citedOpen Access
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium”
Journal of Clinical Medicine·2023· 3 citedOpen Access
page 1 of 33Next →

Frequent Co-authors

Elisa Gremese(12), Salvatore De Vita(10), Maxime Dougados(9), Paul Emery(9), Gerd R Burmester(8), Josef S Smolen(8), Barbara Tolusso(8), Bernard Combe(7), Fausto Salaffi(7), Theodore Pincus(6), Silvia Laura Bosello(6), Daniel Aletaha(5), E. Martín‐Mola(5), Tore K Kvien(5), Ernest Choy(5), Désirée van der Heijde(5), Guido Valesini(5), Alan J. Silman(4), Clifton O. Bingham(4), Iain B. McInnes(4)